Chargement en cours...
PDCT-08. TRAMETINIB AND DABRAFENIB FOR REFRACTORY/INOPERABLE PEDIATRIC LOW GRADE GLIOMAS
BACKGROUND: Low grade gliomas (LGG) are the most common pediatric brain tumors and frequently harbor BRAF mutations or fusions. In cases of refractory and progressing LGG, BRAF and MEK inhibitors now offer an interesting therapeutic approach. However, there are only few cases report on the use BRAF/...
Enregistré dans:
| Publié dans: | Neuro Oncol |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5693001/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.752 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|